DK0984785T3 - Anvendelse af oligosaccharid til forhindring af blodkoagulation i ekstrakorporale blodkredslöb - Google Patents

Anvendelse af oligosaccharid til forhindring af blodkoagulation i ekstrakorporale blodkredslöb

Info

Publication number
DK0984785T3
DK0984785T3 DK98932096T DK98932096T DK0984785T3 DK 0984785 T3 DK0984785 T3 DK 0984785T3 DK 98932096 T DK98932096 T DK 98932096T DK 98932096 T DK98932096 T DK 98932096T DK 0984785 T3 DK0984785 T3 DK 0984785T3
Authority
DK
Denmark
Prior art keywords
oligosaccharide
prevent
blood circulation
extracorporeal
extracorporeal blood
Prior art date
Application number
DK98932096T
Other languages
Danish (da)
English (en)
Inventor
Jean Marc Herbert
Jacobus Christianus J Stiekema
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK0984785T3 publication Critical patent/DK0984785T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
DK98932096T 1997-05-27 1998-05-22 Anvendelse af oligosaccharid til forhindring af blodkoagulation i ekstrakorporale blodkredslöb DK0984785T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201586 1997-05-27

Publications (1)

Publication Number Publication Date
DK0984785T3 true DK0984785T3 (da) 2006-01-30

Family

ID=8228366

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98932096T DK0984785T3 (da) 1997-05-27 1998-05-22 Anvendelse af oligosaccharid til forhindring af blodkoagulation i ekstrakorporale blodkredslöb

Country Status (12)

Country Link
US (3) US6391339B1 (fr)
EP (2) EP0984785B1 (fr)
JP (2) JP2002503270A (fr)
AT (1) ATE307596T1 (fr)
AU (1) AU8211398A (fr)
BR (1) BR9809478A (fr)
CA (1) CA2289522A1 (fr)
DE (1) DE69832066T2 (fr)
DK (1) DK0984785T3 (fr)
ES (1) ES2251090T3 (fr)
NO (1) NO325142B1 (fr)
WO (1) WO1998053829A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE307596T1 (de) * 1997-05-27 2005-11-15 Sanofi Aventis Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe
FR2804328B1 (fr) 2000-01-27 2002-03-15 Hospal Ind Membrane semi-permeable non thrombogene et procede de fabrication
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
CA2782311C (fr) * 2009-12-01 2017-06-27 Robert S. Ward Procede d'elimination de cytokines du sang par des polysaccharides immobilises en surface
ES2647577T3 (es) 2012-06-13 2017-12-22 Exthera Medical Corporation Uso de heparina y carbohidratos para tratar el cáncer
CA2928866C (fr) 2013-11-08 2021-11-09 Exthera Medical Corporation Procedes pour diagnostiquer des maladies infectieuses a l'aide de milieux d'adsorption
CA2946294C (fr) 2014-04-24 2023-03-21 Exthera Medical Corporation Procede d'elimination de bacteries dans le sang a l'aide d'un debit eleve
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
CN113825517A (zh) 2019-05-16 2021-12-21 艾克塞拉医疗公司 调节内皮糖萼结构的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002A (en) * 1841-03-12 Tor and planter for plowing
DE3008993A1 (de) * 1980-03-08 1981-10-01 Röhm Pharma GmbH, 6100 Darmstadt Pharmazeutische zubereitungen
US4331697A (en) * 1980-09-02 1982-05-25 Teijin Limited Novel heparin derivative, method for production thereof, and method for rendering biomedical materials antithrombotic by use of the novel heparin derivative
US4818816A (en) * 1981-04-28 1989-04-04 Choay, S.A. Process for the organic synthesis of oligosaccharides and derivatives thereof
US4987223A (en) * 1981-12-23 1991-01-22 Choay S.A. Derivatives of the uronic acid
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
US4801583A (en) * 1982-01-15 1989-01-31 Choay S.A. Oligosaccharides and their biological applications
JPS63218691A (ja) * 1987-03-09 1988-09-12 Rikagaku Kenkyusho 新規な５糖類化合物及びその製造法並びに抗凝血及び抗血栓剤
EP0300099A1 (fr) * 1987-07-20 1989-01-25 Akzo N.V. Pentasaccharides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
US5252213A (en) * 1989-06-20 1993-10-12 University Of Washington Dry dialysate composition
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
WO1993005825A1 (fr) * 1991-09-20 1993-04-01 Baxter International Inc. Procedes permettant de reduire la thrombogenicite de biomateriaux
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US6391369B1 (en) * 1996-03-27 2002-05-21 Bunge Foods Corporation Selectively hydrogenated high oleic oil compositions and process
IL120722A (en) * 1996-05-08 1999-07-14 Akzo Nobel Nv Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them
ATE307596T1 (de) * 1997-05-27 2005-11-15 Sanofi Aventis Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe

Also Published As

Publication number Publication date
JP2010013455A (ja) 2010-01-21
NO325142B1 (no) 2008-02-11
AU8211398A (en) 1998-12-30
DE69832066D1 (de) 2005-12-01
ES2251090T3 (es) 2006-04-16
EP1593380A3 (fr) 2008-06-11
NO995800D0 (no) 1999-11-26
CA2289522A1 (fr) 1998-12-03
BR9809478A (pt) 2000-06-20
US20070197637A1 (en) 2007-08-23
WO1998053829A1 (fr) 1998-12-03
EP0984785A1 (fr) 2000-03-15
US20020040012A1 (en) 2002-04-04
NO995800L (no) 1999-11-26
US6391339B1 (en) 2002-05-21
EP1593380A2 (fr) 2005-11-09
DE69832066T2 (de) 2006-07-13
JP2002503270A (ja) 2002-01-29
ATE307596T1 (de) 2005-11-15
EP0984785B1 (fr) 2005-10-26

Similar Documents

Publication Publication Date Title
ATE425139T1 (de) Benzamidinderivate
DE60120761D1 (de) Hämodiafiltration/hämofiltrations-patronen
DE69103844D1 (de) Einstufiger Venenkatheter.
DK0453127T3 (da) Behandling af katarakt med 15-keto-prostaglandinforbindelser
DE69206465D1 (de) Peritonealdialyse-Katheter.
SE0103290D0 (sv) Method of controlling a dialysis apparatus
FI885331A (fi) Inhibitering av arteriell, trombotisk ocklusion eller tromboemboli.
ES2119411T3 (es) Combinaciones de proteinas y anticoagulantes tromboliticamente activos, y usos de los mismos.
DK0558529T3 (da) Farmaceutisk præparat til behandling af forlænget koagulationstid
DK0984785T3 (da) Anvendelse af oligosaccharid til forhindring af blodkoagulation i ekstrakorporale blodkredslöb
IT8719479A0 (it) Cannula di drenaggio venoso.
IS2619B (is) Notkun á fásykruhindra á þátt Xa í blöndu með storkuvarnar miðli til að meðhöndla slagæðasegarek.
DE60025698D1 (de) Neue dialysemethode
ITMI20020526A0 (it) Serbatoio di sangue venoso in circuito extracorporeo
DK1051183T3 (da) Peritoneal dialyseoplösning indeholdende modificerede icodextriner
FI952593A0 (fi) Hyytymistä estävä aine
ITTO930757A0 (it) Macchina per dialisi extracorporea.
DK0811376T3 (da) Anvendelse af alkanoyl-L-carnitiner til fremstilling af et lægemiddel til behandling af inflammatoriske tarmsygdomme
DE10084241D2 (de) Heparin mit mittlerer Molmasse
DE60039782D1 (de) Amidinophenylbrenztraubensäure-derivat
DK301190D0 (da) Bioforenelige, stof-specifikke reagenser til behandling af fysiologiske vaesker
ITMI20021553A1 (it) Emoconcentratore in circuito ematico extracorporeo
ATE222103T1 (de) Inklusionskomplexe in waessriger loesung
DK1202754T3 (da) Anvendelse af fibrinogene multimerer i fibrinklæbere
DK332786A (da) Anvendelse af 1,4-dihydropyridinderivater og kombinationer deraf med calcitoniner